Cargando…
Antibacterial therapeutics for the treatment of chytrid infection in amphibians: Columbus’s egg?
BACKGROUND: The establishment of safe and effective protocols to treat chytridiomycosis in amphibians is urgently required. In this study, the usefulness of antibacterial agents to clear chytridiomycosis from infected amphibians was evaluated. RESULTS: Florfenicol, sulfamethoxazole, sulfadiazine and...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488559/ https://www.ncbi.nlm.nih.gov/pubmed/23009707 http://dx.doi.org/10.1186/1746-6148-8-175 |
_version_ | 1782248638230036480 |
---|---|
author | Muijsers, Mariska Martel, An Van Rooij, Pascale Baert, Kris Vercauteren, Griet Ducatelle, Richard De Backer, Patrick Vercammen, Francis Haesebrouck, Freddy Pasmans, Frank |
author_facet | Muijsers, Mariska Martel, An Van Rooij, Pascale Baert, Kris Vercauteren, Griet Ducatelle, Richard De Backer, Patrick Vercammen, Francis Haesebrouck, Freddy Pasmans, Frank |
author_sort | Muijsers, Mariska |
collection | PubMed |
description | BACKGROUND: The establishment of safe and effective protocols to treat chytridiomycosis in amphibians is urgently required. In this study, the usefulness of antibacterial agents to clear chytridiomycosis from infected amphibians was evaluated. RESULTS: Florfenicol, sulfamethoxazole, sulfadiazine and the combination of trimethoprim and sulfonamides were active in vitro against cultures of five Batrachochytrium dendrobatidis strains containing sporangia and zoospores, with minimum inhibitory concentrations (MIC) of 0.5-1.0 μg/ml for florfenicol and 8.0 μg/ml for the sulfonamides. Trimethoprim was not capable of inhibiting growth but, combined with sulfonamides, reduced the time to visible growth inhibition by the sulfonamides. Growth inhibition of B. dendrobatidis was not observed after exposure to clindamycin, doxycycline, enrofloxacin, paromomycin, polymyxin E and tylosin. Cultures of sporangia and zoospores of B. dendrobatidis strains JEL423 and IA042 were killed completely after 14 days of exposure to 100 μg/ml florfenicol or 16 μg/ml trimethoprim combined with 80 μg/ml sulfadiazine. These concentrations were, however, not capable of efficiently killing zoospores within 4 days after exposure as assessed using flow cytometry. Florfenicol concentrations remained stable in a bathing solution during a ten day period. Exposure of Discoglossus scovazzi tadpoles for ten days to 100 μg/ml but not to 10 μg florfenicol /ml water resulted in toxicity. In an in vivo trial, post metamorphic Alytes muletensis, experimentally inoculated with B. dendrobatidis, were treated topically with a solution containing 10 μg/ml of florfenicol during 14 days. Although a significant reduction of the B. dendrobatidis load was obtained, none of the treated animals cleared the infection. CONCLUSIONS: We thus conclude that, despite marked anti B. dendrobatidis activity in vitro, the florfenicol treatment used is not capable of eliminating B. dendrobatidis infections from amphibians. |
format | Online Article Text |
id | pubmed-3488559 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-34885592012-11-05 Antibacterial therapeutics for the treatment of chytrid infection in amphibians: Columbus’s egg? Muijsers, Mariska Martel, An Van Rooij, Pascale Baert, Kris Vercauteren, Griet Ducatelle, Richard De Backer, Patrick Vercammen, Francis Haesebrouck, Freddy Pasmans, Frank BMC Vet Res Research Article BACKGROUND: The establishment of safe and effective protocols to treat chytridiomycosis in amphibians is urgently required. In this study, the usefulness of antibacterial agents to clear chytridiomycosis from infected amphibians was evaluated. RESULTS: Florfenicol, sulfamethoxazole, sulfadiazine and the combination of trimethoprim and sulfonamides were active in vitro against cultures of five Batrachochytrium dendrobatidis strains containing sporangia and zoospores, with minimum inhibitory concentrations (MIC) of 0.5-1.0 μg/ml for florfenicol and 8.0 μg/ml for the sulfonamides. Trimethoprim was not capable of inhibiting growth but, combined with sulfonamides, reduced the time to visible growth inhibition by the sulfonamides. Growth inhibition of B. dendrobatidis was not observed after exposure to clindamycin, doxycycline, enrofloxacin, paromomycin, polymyxin E and tylosin. Cultures of sporangia and zoospores of B. dendrobatidis strains JEL423 and IA042 were killed completely after 14 days of exposure to 100 μg/ml florfenicol or 16 μg/ml trimethoprim combined with 80 μg/ml sulfadiazine. These concentrations were, however, not capable of efficiently killing zoospores within 4 days after exposure as assessed using flow cytometry. Florfenicol concentrations remained stable in a bathing solution during a ten day period. Exposure of Discoglossus scovazzi tadpoles for ten days to 100 μg/ml but not to 10 μg florfenicol /ml water resulted in toxicity. In an in vivo trial, post metamorphic Alytes muletensis, experimentally inoculated with B. dendrobatidis, were treated topically with a solution containing 10 μg/ml of florfenicol during 14 days. Although a significant reduction of the B. dendrobatidis load was obtained, none of the treated animals cleared the infection. CONCLUSIONS: We thus conclude that, despite marked anti B. dendrobatidis activity in vitro, the florfenicol treatment used is not capable of eliminating B. dendrobatidis infections from amphibians. BioMed Central 2012-09-25 /pmc/articles/PMC3488559/ /pubmed/23009707 http://dx.doi.org/10.1186/1746-6148-8-175 Text en Copyright ©2012 Muijsers et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Muijsers, Mariska Martel, An Van Rooij, Pascale Baert, Kris Vercauteren, Griet Ducatelle, Richard De Backer, Patrick Vercammen, Francis Haesebrouck, Freddy Pasmans, Frank Antibacterial therapeutics for the treatment of chytrid infection in amphibians: Columbus’s egg? |
title | Antibacterial therapeutics for the treatment of chytrid infection in amphibians: Columbus’s egg? |
title_full | Antibacterial therapeutics for the treatment of chytrid infection in amphibians: Columbus’s egg? |
title_fullStr | Antibacterial therapeutics for the treatment of chytrid infection in amphibians: Columbus’s egg? |
title_full_unstemmed | Antibacterial therapeutics for the treatment of chytrid infection in amphibians: Columbus’s egg? |
title_short | Antibacterial therapeutics for the treatment of chytrid infection in amphibians: Columbus’s egg? |
title_sort | antibacterial therapeutics for the treatment of chytrid infection in amphibians: columbus’s egg? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488559/ https://www.ncbi.nlm.nih.gov/pubmed/23009707 http://dx.doi.org/10.1186/1746-6148-8-175 |
work_keys_str_mv | AT muijsersmariska antibacterialtherapeuticsforthetreatmentofchytridinfectioninamphibianscolumbussegg AT martelan antibacterialtherapeuticsforthetreatmentofchytridinfectioninamphibianscolumbussegg AT vanrooijpascale antibacterialtherapeuticsforthetreatmentofchytridinfectioninamphibianscolumbussegg AT baertkris antibacterialtherapeuticsforthetreatmentofchytridinfectioninamphibianscolumbussegg AT vercauterengriet antibacterialtherapeuticsforthetreatmentofchytridinfectioninamphibianscolumbussegg AT ducatellerichard antibacterialtherapeuticsforthetreatmentofchytridinfectioninamphibianscolumbussegg AT debackerpatrick antibacterialtherapeuticsforthetreatmentofchytridinfectioninamphibianscolumbussegg AT vercammenfrancis antibacterialtherapeuticsforthetreatmentofchytridinfectioninamphibianscolumbussegg AT haesebrouckfreddy antibacterialtherapeuticsforthetreatmentofchytridinfectioninamphibianscolumbussegg AT pasmansfrank antibacterialtherapeuticsforthetreatmentofchytridinfectioninamphibianscolumbussegg |